Page last updated: 2024-11-02

pd 98059 and Kidney Failure, Chronic

pd 98059 has been researched along with Kidney Failure, Chronic in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daniels, I1
Fletcher, J1
Haynes, AP1

Other Studies

1 other study available for pd 98059 and Kidney Failure, Chronic

ArticleYear
Role of p38 in the priming of human neutrophils by peritoneal dialysis effluent.
    Clinical and diagnostic laboratory immunology, 1999, Volume: 6, Issue:6

    Topics: Antibodies; Calcium-Calmodulin-Dependent Protein Kinases; Cytosol; Enzyme Inhibitors; Flavonoids; Ge

1999